Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PF-04979064 is a dual inhibitor of PI3K and mTOR (Kis = 0.13, 0.111, 0.122, and 1.42 nM for PI3Kα, PI3Kγ, PI3Kδ, and mTOR, respectively).1 It is selective for PI3K and mTOR over a panel of 36 other kinases at 1 µM. PF-04979064 inhibits phosphorylation of Akt in BT-20 breast cancer cells (IC50 = 9.1 nM). It reduces tumor volume by 88% in a U87MG glioblastoma mouse xenograft model when administered at a dose of 40 mg/kg. PF-04979064 also increases alveolar epithelial cell apoptosis in a mouse model of chronic obstructive pulmonary disease (COPD) induced by fine particulate matter less than 2.5 µm (PM2.5).2
WARNING This product is not for human or veterinary use.
1. Discovery of the highly potent PI3K/mTOR dual inhibitor PF-
2. The PI3K/AKT/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter. J. Int. Med. Res. 48(7), 300060520927919 (2020).